These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17092346)

  • 1. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Public Health; 2006 Nov; 6():277. PubMed ID: 17092346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General practitioners' beliefs about effectiveness and intentions to recommend smoking cessation services: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Fam Pract; 2007 Jul; 8():39. PubMed ID: 17615061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    Nicotine Tob Res; 2008 Aug; 10(8):1405-13. PubMed ID: 18686189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
    McEwen A; West R; Owen L
    BMC Fam Pract; 2001; 2():6. PubMed ID: 11701091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy.
    Herbert R; Coleman T; Britton J
    Nicotine Tob Res; 2005 Aug; 7(4):541-6. PubMed ID: 16085525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
    Kotz D; Wagena EJ; Wesseling G
    Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioners' views on and referral to NHS smoking cessation services.
    McEwen A; West R; Owen L; Raw M
    Public Health; 2005 Apr; 119(4):262-8. PubMed ID: 15733685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician beliefs regarding effectiveness of tobacco dependence treatments: results from the NJ Health Care Provider Tobacco Survey.
    Steinberg MB; Delnevo CD
    J Gen Intern Med; 2007 Oct; 22(10):1459-62. PubMed ID: 17726636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
    Paul CL; Tzelepis F; Walsh RA; Turner R
    Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation and nicotine replacement therapy in current primary maternity care.
    Pullon S; Webster M; McLeod D; Benn C; Morgan S
    Aust Fam Physician; 2004; 33(1-2):94-6. PubMed ID: 14988974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking for boomerang effects: a pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban.
    Durkin S; Wakefield M; Spittal M
    Addict Behav; 2006 Dec; 31(12):2158-68. PubMed ID: 16567056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.